BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 22412194)

  • 21. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T
    Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated liver dendritic cells generate strong acquired immunity in alpha-galactosylceramide treatment.
    Sasakawa A; Tatsumi T; Takehara T; Yamaguchi S; Yamamoto M; Ohkawa K; Miyagi T; Hayashi N
    J Hepatol; 2009 Jun; 50(6):1155-62. PubMed ID: 19376606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide.
    Kajiwara T; Tomita Y; Okano S; Iwai T; Yasunami Y; Yoshikai Y; Nomoto K; Yasui H; Tominaga R
    Transplantation; 2007 Jan; 83(2):184-92. PubMed ID: 17264815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.
    Fujii S; Shimizu K; Hemmi H; Fukui M; Bonito AJ; Chen G; Franck RW; Tsuji M; Steinman RM
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11252-7. PubMed ID: 16844772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
    Carnaud C; Lee D; Donnars O; Park SH; Beavis A; Koezuka Y; Bendelac A
    J Immunol; 1999 Nov; 163(9):4647-50. PubMed ID: 10528160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate, antigen-independent role for T cells in the activation of the immune system by Propionibacterium acnes.
    Tchaptchet S; Kirberg J; Freudenberg N; Schamel WW; Galanos C; Freudenberg MA
    Eur J Immunol; 2010 Sep; 40(9):2506-16. PubMed ID: 20690177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells.
    Chuang YH; Wang TC; Jen HY; Yu AL; Chiang BL
    J Immunol; 2011 Apr; 186(8):4687-92. PubMed ID: 21383248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential role of bystander cytotoxic CD122+CD8+ T cells for the antitumor immunity induced in the liver of mice by alpha-galactosylceramide.
    Nakagawa R; Inui T; Nagafune I; Tazunoki Y; Motoki K; Yamauchi A; Hirashima M; Habu Y; Nakashima H; Seki S
    J Immunol; 2004 Jun; 172(11):6550-7. PubMed ID: 15153469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
    Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA
    J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.
    Macho-Fernandez E; Cruz LJ; Ghinnagow R; Fontaine J; Bialecki E; Frisch B; Trottein F; Faveeuw C
    J Immunol; 2014 Jul; 193(2):961-9. PubMed ID: 24913977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NKT and tolerance.
    Diana J; Beaudoin L; Gautron AS; Lehuen A
    Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo.
    Simkins HM; Hyde E; Farrand KJ; Ong ML; Degli-Esposti MA; Hermans IF; Ronchese F
    J Leukoc Biol; 2011 May; 89(5):753-62. PubMed ID: 21297009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells.
    Kato M; Nakamura Y; Suda T; Ozawa Y; Inui N; Seo N; Nagata T; Koide Y; Kalinski P; Nakamura H; Chida K
    Cancer Immunol Immunother; 2011 Jul; 60(7):1029-38. PubMed ID: 21519830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of marginal zone B lymphocytes in invariant NKT cell activation.
    Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
    J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
    Smyth MJ; Crowe NY; Pellicci DG; Kyparissoudis K; Kelly JM; Takeda K; Yagita H; Godfrey DI
    Blood; 2002 Feb; 99(4):1259-66. PubMed ID: 11830474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.
    Kawakami K; Kinjo Y; Yara S; Koguchi Y; Uezu K; Nakayama T; Taniguchi M; Saito A
    Infect Immun; 2001 Jan; 69(1):213-20. PubMed ID: 11119508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
    Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
    Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.